Number of lipid-lowering medications and attainment of lipid goals in familial hypercholesterolemia patients: Data from the Latvian registry von Nesterovics, G., Saripo, V., Meiere, R., Terauda, E., Skudrina, G., Gilis, D., Erglis, A., Latkovskis, G.

Volltext

Genetic spectrum in Latvian patients with familial hypercholesterolemia: First data from a whole genome sequencing study von Latkovskis, G., Rescenko, R., Nesterovics, G., Briviba, M., Saripo, V., Gilis, D., Meiere, R., Terauda, E., Skudrina, G., Erglis, A., Chora, J., Bourbon, M., Klovins, J.

Volltext

Impact of 2019 EAS/ESC dyslipidaemia guidlines on management of FH patients: Reclassification of risk and LDL-C goal attainement in the Latvian registry von Gilis, D., Nesterovics, G., Meiere, R., Terauda, E., Saripo, V., Erglis, A., Latkovskis, G.

Volltext

Correlation Between Tendon Xanthomas And Atherosclerotic Disease In Coronary And Brachiocephalic Arteries In Patients With Familial Hypercholesterolemia von Nesterovics, G., Saripo, V., Gilis, D., Upena-Roze, A., Erglis, A., Latkovskis, G.

Volltext

Prevalence of premature asymptomatic coronary artery disease in patients included in the Latvian registry of familial hypercholesterolemia von Saripo, V., Gilis, D., Nesterovics, G., Upena-Roze, A., Zvaigzne, L., Erglis, A., Latkovskis, G.

Volltext

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) von Vallejo-Vaz, AJ, Soran, H, Alnouri, F, Binder, CJ, Davletov, K, Durst, R, Harada-Shiba, M, Maher, V, Nordestgaard, BG, Petrulioniene, Z, Tybjæg-Hansen, A, Bruckert, E, Toplak, H, Huber, K, Kleemann, L, Scholl-Bürgi, S, Sablon, G, Sisic, I, Jannes, CE, Yotov, Y, Cermakova, L, Hegele, RA, Ye, P, Qi, J, Jiao, J, Qu, Y, Ceska, R, Adamkova, V, Cepova, J, Halamkova, H, Sultan, A, Valero, R, Sonntag, A, Usme, MMN, Füllgraf-Horst, S, Wiener, J, Kopf, S, Tarr, A, Steinhagen-Thiessen, E, Julius, U, Skalidis, E, Kiouri, E, Zacharis, E, Koutsogianni, A-D, Benczúr, B, Nagy, G, Altaey, M, Jabbar, AA, Ellis, A, Nagahama, K, Nesterovics, G, Saripo, V, Terauda, E, Jambart, S, Muid, SA, Ibrahim, KS, Hafidz, MIA, Rosli, MM, Annamalai, M, Mehta, R, Rodriguez, B, Zazueta, AR, Portano, JDM, Lopez, HA, Gonzalez, PAC, Portilla, NC, Rivera, KJA, Andrade, MHF, De Leon, LEG, Guzman, BG, Garcia, JJG, Cuellar, JCG, Rodriguez, EAR, Isara, A, Obaseki, DE, Al-Kindi, M, Starostecka, E, Woś, M, Silva, F, Rato, Q, Correia, S, Safarova, M, Almigbal, TH, Altaradi, H, Popovic, L, Singh, S, Jin, TCS, Battelino, T, Mlinaric, M, Wolmarans, KH, Ganokroj, P, Ildizli, M, Kilic, S, Sonmez, A, Topcu, S, Yigit, Z, Sabbour, H, Reyes, X, Alieva, RB, Hoshimov, SU

Volltext

PO341 Do Patients Who Use Different Oral Anticoagulants Have a Statistically Significant Difference for Potential Drug-Drug Interactions? von Pupkevica, I., Apsite, K., Nesterovics, N., Jubele, K., Cgojeva-Sproge, I., Kamzola, G., Strelnieks, A., Kalejs, O., Lejnieks, A.

Volltext